Explore

Trendline Trendline
Turn Therapeutics Appoints Former FDA Commissioner Dr. Stephen M. Hahn to Lead Clinical and Regulatory Strategy

Turn Therapeutics Appoints Former FDA Commissioner Dr. Stephen M. Hahn to Lead Clinical and Regulatory Strategy

Turn Therapeutics Appoints Former FDA Commissioner Dr. Stephen M. Hahn to Lead Clinical and Regulatory Strategy
Trendline Trendline
Harbour BioMed Unveils Promising Preclinical Data for AI-Enabled Drug LET003 Targeting Obesity

Harbour BioMed Unveils Promising Preclinical Data for AI-Enabled Drug LET003 Targeting Obesity

Harbour BioMed Unveils Promising Preclinical Data for AI-Enabled Drug LET003 Targeting Obesity
Trendline Trendline
Piramal Pharma Solutions Expands Manufacturing Capabilities in Michigan to Enhance Drug Development

Piramal Pharma Solutions Expands Manufacturing Capabilities in Michigan to Enhance Drug Development

Piramal Pharma Solutions Expands Manufacturing Capabilities in Michigan to Enhance Drug Development
Trendline Trendline
MSD's Sac-TMT Shows Promise in Phase 3 Endometrial Cancer Trial

MSD's Sac-TMT Shows Promise in Phase 3 Endometrial Cancer Trial

MSD's Sac-TMT Shows Promise in Phase 3 Endometrial Cancer Trial
Trendline Trendline
ImmunityBio Secures Exclusive U.S. Rights to Tokyo Strain of BCG to Address Bladder Cancer Treatment Shortage

ImmunityBio Secures Exclusive U.S. Rights to Tokyo Strain of BCG to Address Bladder Cancer Treatment Shortage

ImmunityBio Secures Exclusive U.S. Rights to Tokyo Strain of BCG to Address Bladder Cancer Treatment Shortage
Trendline Trendline
Sumitomo Pharma America Presents Promising Vibegron Data for Older Men with Overactive Bladder

Sumitomo Pharma America Presents Promising Vibegron Data for Older Men with Overactive Bladder

Sumitomo Pharma America Presents Promising Vibegron Data for Older Men with Overactive Bladder
Trendline Trendline
KORU Medical Systems Showcases Benefits of FreedomEDGE Infusion System at Oncology Nursing Congress

KORU Medical Systems Showcases Benefits of FreedomEDGE Infusion System at Oncology Nursing Congress

KORU Medical Systems Showcases Benefits of FreedomEDGE Infusion System at Oncology Nursing Congress
Trendline Trendline
ImmunityBio Secures U.S. Agreement for Tokyo Strain of BCG to Address Bladder Cancer

ImmunityBio Secures U.S. Agreement for Tokyo Strain of BCG to Address Bladder Cancer

ImmunityBio Secures U.S. Agreement for Tokyo Strain of BCG to Address Bladder Cancer
Trendline Trendline
FDA Approves AstraZeneca's Baxfendy, a New Class of Hypertension Drug

FDA Approves AstraZeneca's Baxfendy, a New Class of Hypertension Drug

FDA Approves AstraZeneca's Baxfendy, a New Class of Hypertension Drug
Trendline Trendline
FDA Alignment and AI Integration Critical for Rare Disease Drug Development

FDA Alignment and AI Integration Critical for Rare Disease Drug Development

FDA Alignment and AI Integration Critical for Rare Disease Drug Development
Trendline Trendline
ImmunityBio Secures U.S. Agreement for Tokyo Strain of BCG to Address Supply Shortage

ImmunityBio Secures U.S. Agreement for Tokyo Strain of BCG to Address Supply Shortage

ImmunityBio Secures U.S. Agreement for Tokyo Strain of BCG to Address Supply Shortage
Trendline Trendline
Johnson Johnson's New Psoriasis Pill Aims to Revolutionize Treatment Market

Johnson Johnson's New Psoriasis Pill Aims to Revolutionize Treatment Market

Johnson Johnson's New Psoriasis Pill Aims to Revolutionize Treatment Market